index - Génétique et physiopathologie des MNM liées à la matrice extracellulaire et du noyau Accéder directement au contenu

Dernières publications

Chiffres clés

120 Publications avec texte intégral
1 Données de recherche

Open Access

47 %

Mots clés

Allele-specific silencing Emery-Dreifuss muscular dystrophy Nuclear envelope BiP Autophagosome maturation Lamins Emerin C elegans Muscle COVID-19 COL1A1 Cardiology LMNA-related congenital muscular dystrophy Mutations RNA interference Treatment COL6A1 POPDC1 Lamin A/C nuclei Adult SMA Maladies rares et orphelines AAV VECTOR Heart Angiotensin-converting enzyme inhibitor Actionable gene Allele‐specific silencing therapy Mouse C2C12 A-type lamins Angiotensin-converting enzyme inhibitors Heart failure Cardiac conduction system Actionability LMNA gene Neuromuscular diseases Clinical trial Laminopathies Lamin A/C Diagnosis LGMD COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Muscular dystrophy MD Cancer CRISPR IPSC Dilated cardiomyopathy Biomarker Rare diseases Myologie Dystrophine Biological sciences Errance diagnostique CSF protein Myopathies Muscle biopsy Cardiomyopathy CMTX Muscle MRI GNE Gene therapy Maladies rares Lamin A/C LMNA gene Becker muscular dystrophy Hypermobile EDS Ehlers‐Danlos Syndrome Myotubes Skeletal muscle Muscular dystrophy Laminopathy Alternative splicing INPP5K Regeneration Base de données FAIR Rare neuromuscular diseases Butyrylcholinesterase Laminopathie AAV Congenital muscular dystrophy Allele-specific silencing therapy Titin Calcium handling Connective tissue Dynamin 2 Myopathy Exome Acetyltransferase Next generation sequencing Duchenne muscular dystrophy BVES Joint laxity Centronuclear myopathy Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Dystrophie musculaire Cancer biomarkers LMNA Patient registry Therapy A-type lamin Treatment delay Myogenesis